Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 9:23:100811.
doi: 10.1016/j.conctc.2021.100811. eCollection 2021 Sep.

Clinical trials proposed for the VA Cooperative Studies Program: Success rates and factors impacting approval

Affiliations

Clinical trials proposed for the VA Cooperative Studies Program: Success rates and factors impacting approval

David R Burnaska et al. Contemp Clin Trials Commun. .

Abstract

The process by which funding organizations select among the myriad number of proposals they receive is a matter of significant concern for researchers and the public alike. Despite an extensive literature on the topic of peer review and publications on criteria by which clinical investigations are reviewed, publications analyzing peer review and other processes leading to government funding decisions on large multi-site clinical trials proposals are sparse. To partially address this gap, we reviewed the outcomes of scientific and programmatic evaluation for all letters of intent (LOIs) received by the Department of Veterans Affairs (VA) Cooperative Studies Program (CSP) between July 4, 2008, and November 28, 2016. If accepted, these LOIs represented initial steps towards later full proposals that also underwent scientific peer review. Twenty-two of 87 LOIs were ultimately funded and executed as CSP projects, for an overall success rate of 25%. Most proposals which received a negative decision did so prior to submission of a full proposal. Common reasons for negative scientific review of LOIs included investigator inexperience, perceived lack of major scientific impact, lack of preliminary data and flawed or confused experimental design, while the most common reasons for negative reviews of final proposals included questions of scientific impact and issues of study design, including outcome measures, randomization, and stratification. Completed projects have been published in high impact clinical journals. Findings highlight several factors leading to successfully obtaining funding support for clinical trials. While our analysis is restricted to trials proposed for CSP, the similarities in review processes with those employed by the National Institutes of Health and the Patient Centered Outcomes Research Institute suggest the possibility that they may also be important in a broader context.

Keywords: Clinical trials; Letters of intent; Peer review; Success rates; Veterans.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flowchart outlining the basics of the VA Cooperative Studies Program proposal development and review process. As noted in the text, letters of intent that are flagged for revision or pre-planning may receive the assistance of one of the CSP Statistical Coordinating Centers as a part of the revision or approval process.

Similar articles

Cited by

References

    1. Huang G.D., Ferguson R.E., Peduzzi P.N., O'Leary T.J. Scientific and organizational collaboration in comparative effectiveness research: the VA Cooperative Studies Program model. Am. J. Med. 2010;123:e24–e31. doi: 10.1016/j.amjmed.2010.10.005. - DOI - PubMed
    1. Concato J., Peduzzi P., Huang G.D., O'Leary T.J., Kupersmith J. Comparative effectiveness research: what kind of studies do we need? J. Invest. Med. 2010;58:764–769. 10.231/JIM.0b013e3181e3d2af. - PubMed
    1. O'Leary T.J., Dominitz J.A., Chang K.-M. Veterans affairs office of research and development: research programs and emerging opportunities in digestive diseases research. Gastroenterology. 2015;149:1652–1661. doi: 10.1053/j.gastro.2015.10.021. - DOI - PMC - PubMed
    1. Tucker W.B. The evolution of the cooperative studies in the chemotherapy of tuberculosis of the Veterans Administration and Armed Forces of the U.S.A. An account of the evolving education of the physician in clinical pharmacology. Bibl. Tuberc. 1960;15:1–68. http://www.ncbi.nlm.nih.gov/pubmed/13839748 - PubMed
    1. Pier E.L., Brauer M., Filut A., Kaatz A., Raclaw J., Nathan M.J., Ford C.E., Carnes M. Low agreement among reviewers evaluating the same NIH grant applications. Proc. Natl. Acad. Sci. Unit. States Am. 2018;115:2952–2957. doi: 10.1073/pnas.1714379115. - DOI - PMC - PubMed

LinkOut - more resources